Repotrectinib in a Patient With NTRK Fusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome

被引：1
|
作者：
Yun, Karen M. [1 ]
Narezkina, Anna [2 ,3 ]
Redfern, Charles [4 ]
Velasco, Katherine [1 ]
Bazhenova, Lyudmila [1 ]
机构：
[1] UC San Diego Hlth, Moores Canc Ctr, Div Hematol Oncol, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA
[2] Univ Calif Med Ctr, Div Cardiol, La Jolla, CA USA
[3] Sulpizio Cardiovasc Ctr, La Jolla, CA USA
[4] Sharp HealthCare, Med Oncol, San Diego, CA USA
来源：
JCO PRECISION ONCOLOGY | 2024年 / 8卷
关键词：
SOLID TUMORS; LAROTRECTINIB;
D O I：
10.1200/PO.23.00265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Repotrectinib in a patient with NTRK fusion-positive pancreatic carcinoma and congenital long QT syndrome.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Congenital Long QT Syndrome
    Wirsching, Megan
    AACN ADVANCED CRITICAL CARE, 2010, 21 (01) : 112 - 116
  • [42] Acquired long QT syndrome: as risky as congenital long QT syndrome?
    Wong, Leonie C. H.
    Behr, Elijah R.
    EUROPACE, 2012, 14 (03): : 310 - 311
  • [43] Congenital long QT syndrome
    Lia Crotti
    Giuseppe Celano
    Federica Dagradi
    Peter J Schwartz
    Orphanet Journal of Rare Diseases, 3
  • [44] CONGENITAL LONG QT SYNDROME
    Pellizzon, Oscar A.
    Nannini, Sebastian
    Catalano, Antonia
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2008, 37 (02): : 118 - 129
  • [45] Congenital long QT syndrome
    Haverkamp, Wilhelm
    HERZ, 2007, 32 (03) : 201 - 205
  • [46] CONGENITAL LONG QT SYNDROME MASKED BY AQUIRED LONG QT SYNDROME
    Hayashi, Hideka
    Fujita, Hiroshi
    Takahashi, Yoshimi
    Yamanaka, Shinsuke
    Shinozaki, Tsuyoshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1254 - 1254
  • [47] Successful Targeted Therapy of Refractory Pediatric ETV6-NTRK3 Fusion-Positive Secretory Breast Carcinoma
    Shukla, Neerav
    Roberts, Stephen S.
    Baki, Mollah O.
    Mushtaq, Qazi
    Goss, Paul E.
    Park, Ben H.
    Gundem, Gunes
    Tian, Ken
    Geiger, Heather
    Redfield, Kristie
    Behr, Gerald
    Benayed, Ryma
    Zehir, Ahmet
    Hechtman, Jaclyn F.
    Darnell, Robert B.
    Papaemmanuil, Elli
    Ladanyi, Marc
    Ku, Nora
    Kung, Andrew L.
    Baselga, Jose
    Drilon, Alexander
    Hyman, David M.
    JCO PRECISION ONCOLOGY, 2017, 1
  • [48] Progression free survival of larotrectinib in patients with NTRK fusion-positive tumors: a systematic review
    Sumampow, M. M. A.
    Fu, R. C. E.
    Delvino, D.
    Albert, N.
    Danisha, P. A. C.
    Satcitta, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S1353 - S1353
  • [49] Clinicopathologic Spectrum of NTRK fusion-positive Tumors Detected by Clinical RNA Sequencing Panel
    Garcia, Annie
    Reuther, Jacquelyn
    Voicu, Horatiu
    Mohila, Carrie
    Adesina, Adekunle
    Schady, Deborah
    Wang, Wei-Lien
    Lazar, Alexander
    Lopez-Terrada, Dolores
    Lin, Frank
    Venkatramani, Rajkumar
    Plon, Sharon
    Parsons, Williams
    Fisher, Kevin
    Roy, Angshumoy
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 36 - 37
  • [50] The Value of Online CME in the Multidisciplinary Care of Patients with NTRK Fusion-Positive Thyroid Cancer
    Worst, M. A.
    Carothers, A.
    Surducan, M.
    Sipos, J.
    Wirth, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E50 - E51
12345